Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2020 | Amyloidosis classification and epidemiology

Joan Bladé • 4 Sep 2020
ISA 2020
Amyloidosis Rare Diseases

Joan Blade, MD, PhD, Hospital Clínic de Barcelona, Barcelona, Spain, discusses amyloidosis classification and epidemiology. Specifically highlighted is AL amyloidosis, systemic amyloidosis, ATTR amyloidosis and other forms of secondary amyloidosis related to inflammatory processes. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Joan Bladé

2:36
Looking forward to ISA 2022
Joan Bladé • 12 May 2022
1:02
How the amyloidosis treatment landscape has transformed in recent years
Joan Bladé • 12 May 2022
3:26
Managing and treating renal impairment in multiple myeloma
Joan Bladé • 12 May 2022
10:09
ISA 2020: continuing the amyloidosis conversation
Joan Bladé • 2 Sep 2020

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals